BackBiotech Acquisition Overview

Biotech Acquisition Current Cash

Track Biotech Acquisition's current cash ($13K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$13145.00
96.73% YoYΔ $-389252.00 vs prior year quarter

Peer average

Loading

Biotech Acquisition Current Cash History

Loading

Biotech Acquisition vs. peers: Current Cash Comparison

Loading

Biotech Acquisition Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biotech Acquisition (BIOT) FAQ

As of the most recent data (September 2022), BIOT shows a current cash of $13K. That compares with $400K in the prior-year period — down 96.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOT's current cash is now $13K (was $400K) — a 96.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition is outperforming or lagging.

Tracking BIOT's current cash over time shows whether Biotech Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $13K That compares with $400K in the prior-year period — down 96.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Biotech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $13K) with ownership activity and broader fundamentals.